A laborant at the State Health Authorities of Baden-Wuerttemberg works on a test sample of a suspected case of the 2019 Novel Coronavirus in Stuttgart, southern Germany on January 29, 2020. Marijan Murat / DPA / AFP.
Germany has authorised its first clinical test of a vaccine for the novel coronavirus, the country’s regulatory body said Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.
“The Paul-Ehrlich-Institut… has authorised the first clinical trial of a vaccine against COVID-19 in Germany,” the regulatory body PEI said in a statement.
The trial, which was only the fourth to have been authorised worldwide, was a “significant step” in making a vaccine “available as soon as possible”, the institute added.
It said that approval was the “result of a careful assessment of the potential risk/benefit profile of the vaccine candidate”.
The trials will see “200 healthy volunteers aged between 18 and 55 years” vaccinated with variants of the RNA vaccine, while the second phase could see the inclusion of volunteers who belonged to high-risk groups.
READ ALSO: South Africa To Deploy More Troops For COVID-19 Lockdown
Neither PEI nor the developers specified when the trial will begin, though Biontech claimed in a statement that it would be “soon” and “ahead of our expectations”.
The PEI also claimed that “further clinical trials of COVID-19 vaccine candidates will start in Germany in the next few months”.
AFP
"Fiscal measures will complement monetary control tools and diesel prices will fall further below 1000…
Everton sit just three points above the relegation zone with nine games left in their…
"I'm getting tired of putting up with being dragged by everyone in my life and…
The governor said he remained resolute in steering Kaduna to the path of progress using…
Spurs have now come from behind to win in four of their last five home…
The Founder of The Chair Centre Group and former Chairperson of First Bank of Nigeria…